Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tanila

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Physiological Research|March 3, 2020
Elevated age-related cortical iron, ferritin and amyloid plaques in APP(swe)/PS1(deltaE9) transgenic mouse model of Alzheimer's diseaseH Svobodová, D Kosnáč, Z Balázsiová, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|January 24, 2020
Iron-oxide minerals in the human tissuesH Svobodova, D Kosnáč, H Tanila, et al.
Journal of Cellular and Molecular Medicine|January 23, 2008
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathologyR Liu, X-W Zhou, H Tanila, et al.
Journal of Neurochemistry|November 29, 2007
Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type miceR Minkeviciene, J Ihalainen, T Malm, et al.
Neurobiology of Aging|January 26, 2010
Characterization of a novel transgenic rat carrying human tau with mutation P301LP Korhonen, T van Groen, A Thornell, et al.
Neurobiology of Disease|August 28, 2007
Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD)C R Hooijmans, F Rutters, P J Dederen, et al.
Experimental Neurology|May 22, 2025
Intracerebroventricular phospho-tau immunotherapy alleviates cortical phospho-tau burden and motor phenotype in a neuron-specific P301S tauopathy mouseS Kemppainen, M Aramburu-Núñez, H Koivisto, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Physiological Research|March 3, 2020
Elevated age-related cortical iron, ferritin and amyloid plaques in APP(swe)/PS1(deltaE9) transgenic mouse model of Alzheimer's diseaseH Svobodová, D Kosnáč, Z Balázsiová, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|January 24, 2020
Iron-oxide minerals in the human tissuesH Svobodova, D Kosnáč, H Tanila, et al.
Journal of Cellular and Molecular Medicine|January 23, 2008
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathologyR Liu, X-W Zhou, H Tanila, et al.
Journal of Neurochemistry|November 29, 2007
Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type miceR Minkeviciene, J Ihalainen, T Malm, et al.
Neurobiology of Aging|January 26, 2010
Characterization of a novel transgenic rat carrying human tau with mutation P301LP Korhonen, T van Groen, A Thornell, et al.
Neurobiology of Disease|August 28, 2007
Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD)C R Hooijmans, F Rutters, P J Dederen, et al.
Experimental Neurology|May 22, 2025
Intracerebroventricular phospho-tau immunotherapy alleviates cortical phospho-tau burden and motor phenotype in a neuron-specific P301S tauopathy mouseS Kemppainen, M Aramburu-Núñez, H Koivisto, et al.
Pageof 6